Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood

Open access

Abstract

AIMS: The antidiabetic drug metformin is currently used prior and during pregnancy for polycystic ovary syndrome, as well as during gestational diabetes mellitus. We investigated the effects of prenatal metformin exposure on the metabolic phenotype of the offspring during adulthood in mice. METHODS: Metformin (300 mg/kg) or vehicle was administered orally to dams on regular diet from the embryonic day E0.5 to E17.5. Gene expression profiles in liver and brain were analysed from 4-day old offspring by microarray. Body weight development and several metabolic parameters of offspring were monitored both during regular diet (RD-phase) and high fat diet (HFD-phase). At the end of the study, two doses of metformin or vehicle were given acutely to mice at the age of 20 weeks, and Insig-1 and GLUT4 mRNA expressions in liver and fat tissue were analysed using qRT-PCR. RESULTS: Metformin exposed fetuses were lighter at E18.5. There was no effect of metformin on the maternal body weight development or food intake. Metformin exposed offspring gained more body weight and mesenteric fat during the HFD-phase. The male offspring also had impaired glucose tolerance and elevated fasting glucose during the HFD-phase. Moreover, the expression of GLUT4 mRNA was down-regulated in epididymal fat in male offspring prenatally exposed to metformin. Based on the microarray and subsequent qRT-PCR analyses, the expression of Insig-1 was changed in the liver of neonatal mice exposed to metformin prenatally. Furthermore, metformin up-regulated the expression of Insig-1 later in development. Gene set enrichment analysis based on preliminary microarray data identified several differentially enriched pathways both in control and metformin exposed mice. CONCLUSIONS: The present study shows that prenatal metformin exposure causes long-term programming effects on the metabolic phenotype during high fat diet in mice. This should be taken into consideration when using metformin as a therapeutic agent during pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0056594

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic timeline of the study. Metformin was administered from E0.5 to E17.5 to dams on a regular diet. Week 0 denotes the birth. GTT = glucose tolerance test.
Figure 1 Schematic timeline of the study. Metformin was administered from E0.5 to E17.5 to dams on a regular diet. Week 0 denotes the birth. GTT = glucose tolerance test.CC BY · PubMed Central
Figure 2 Body weight development during gestation and the weight of the fetuses at E18.5. Body weight development of the dams does not change due to metformin treatment (2A) (n = 5–7). Prenatal metformin exposure decreases body weight of the fetuses (2B) (n(litters) = 3, n(fetuses) = 23 for both groups). Black circles (•) = prenatal control, white circles (○) = prenatal metformin. Data expressed as mean ± SEM. ***P<0.0001 by Student's t-test.
Figure 2 Body weight development during gestation and the weight of the fetuses at E18.5. Body weight development of the dams does not change due to metformin treatment (2A) (n = 5–7). Prenatal metformin exposure decreases body weight of the fetuses (2B) (n(litters) = 3, n(fetuses) = 23 for both groups). Black circles (•) = prenatal control, white circles (○) = prenatal metformin. Data expressed as mean ± SEM. ***P<0.0001 by Student's t-test.CC BY · PubMed Central
Figure 3 Body weight development of the offspring during RD and HFD. Body weight development of the female (A) and male offspring (B) (n = 13–18). The dotted vertical line indicates the diet change from RD to HFD. Black circles (•) = prenatal control, white circles (○) = prenatal metformin. Total body weight change during RD and HFD for female (C, E) offspring and male (D, F) offspring. Data expressed as mean ± SEM. *P<0.05, **P<0.001, ***P<0.0001 by Bonferroni post hoc tests for body weight development and Student's t-test for total body weight change.
Figure 3 Body weight development of the offspring during RD and HFD. Body weight development of the female (A) and male offspring (B) (n = 13–18). The dotted vertical line indicates the diet change from RD to HFD. Black circles (•) = prenatal control, white circles (○) = prenatal metformin. Total body weight change during RD and HFD for female (C, E) offspring and male (D, F) offspring. Data expressed as mean ± SEM. *P<0.05, **P<0.001, ***P<0.0001 by Bonferroni post hoc tests for body weight development and Student's t-test for total body weight change.CC BY · PubMed Central
Figure 4 Body composition.
Figure 4 Body composition.CC BY · PubMed Central
Figure 5 Weights of WAT depots. WAT depots were excised at the age of 20 weeks (n = 9–16). Black columns = prenatal control, white columns = prenatal metformin. Data expressed as mean ± SEM. *P<0.05, **P<0.001 by Student's t-test or Mann-Whitney test.
Figure 5 Weights of WAT depots. WAT depots were excised at the age of 20 weeks (n = 9–16). Black columns = prenatal control, white columns = prenatal metformin. Data expressed as mean ± SEM. *P<0.05, **P<0.001 by Student's t-test or Mann-Whitney test.CC BY · PubMed Central
Figure 6 Prenatal metformin exposure alters glucose tolerance in the male offspring during HFD in adulthood. Glucose tolerance was tested during RD (A, B) (age = 9–10 weeks) and after 5–6 weeks of a HFD intervention (age = 15–16 weeks) (C, D) (n = 12–19) Black circles (•) = prenatal control, white circles (○) = prenatal metformin. Data expressed as mean ± SEM. *P<0.05 by Bonferroni post hoc tests.
Figure 6 Prenatal metformin exposure alters glucose tolerance in the male offspring during HFD in adulthood. Glucose tolerance was tested during RD (A, B) (age = 9–10 weeks) and after 5–6 weeks of a HFD intervention (age = 15–16 weeks) (C, D) (n = 12–19) Black circles (•) = prenatal control, white circles (○) = prenatal metformin. Data expressed as mean ± SEM. *P<0.05 by Bonferroni post hoc tests.CC BY · PubMed Central
Figure 7 Prenatal metformin exposure leads to elevated fasting glucose during HFD in the male offspring. Fasting glucose was significantly elevated after a 10-week HFD intervention in metformin exposed male offspring. Time points: RD = 9–10 weeks, early HFD 16 weeks, late HFD = 19 weeks. Black circles (•) = prenatal control, white circles (○) = prenatal metformin (n = 12–16). Data expressed as mean ± SEM. ***P<0.0001 by Bonferroni post hoc tests.
Figure 7 Prenatal metformin exposure leads to elevated fasting glucose during HFD in the male offspring. Fasting glucose was significantly elevated after a 10-week HFD intervention in metformin exposed male offspring. Time points: RD = 9–10 weeks, early HFD 16 weeks, late HFD = 19 weeks. Black circles (•) = prenatal control, white circles (○) = prenatal metformin (n = 12–16). Data expressed as mean ± SEM. ***P<0.0001 by Bonferroni post hoc tests.CC BY · PubMed Central
Figure 8 Hepatic gene expression profile in the neonatal offspring. Heatmap with hierarchical clustering of the hepatic gene expression profile of 4-day old offspring (n = 3 in each group).
Figure 8 Hepatic gene expression profile in the neonatal offspring. Heatmap with hierarchical clustering of the hepatic gene expression profile of 4-day old offspring (n = 3 in each group).CC BY · PubMed Central
Figure 9 Hepatic Insig-1 expression is up-regulated by prenatal exposure to metformin. Hepatic Insig-1 expression in female and male offspring at day 4 (n = 3–7) (A, B).
Figure 9 Hepatic Insig-1 expression is up-regulated by prenatal exposure to metformin. Hepatic Insig-1 expression in female and male offspring at day 4 (n = 3–7) (A, B).CC BY · PubMed Central
Figure 10 Insig-1 and GLUT4 mRNA expression at the end of the HFD-phase and after sub-acute metformin exposure. Insig-1 expression in liver (A) and GLUT4 expression in epididymal fat (B) at the study endpoint at the age of 20 weeks (n = 6–8). Columns grouped to the left = prenatal control, columns grouped to the right = prenatal metformin. Sub-acute vehicle = black, sub-acute metformin = white. Data expressed as mean ± SEM. *P<0.05 and **P<0.001 by 2-way ANOVA and Bonferroni post hoc tests.
Figure 10 Insig-1 and GLUT4 mRNA expression at the end of the HFD-phase and after sub-acute metformin exposure. Insig-1 expression in liver (A) and GLUT4 expression in epididymal fat (B) at the study endpoint at the age of 20 weeks (n = 6–8). Columns grouped to the left = prenatal control, columns grouped to the right = prenatal metformin. Sub-acute vehicle = black, sub-acute metformin = white. Data expressed as mean ± SEM. *P<0.05 and **P<0.001 by 2-way ANOVA and Bonferroni post hoc tests.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 92

Metadata

Authors
Salomäki, H., Vähätalo, L. H., Laurila, K., Jäppinen, N. T., Penttinen, A.-M., Ailanen, L., Ilyasizadeh, J., Pesonen, U., & Koulu, M.
Affiliations
  • University of Turku (FI)
  • Aalto University (FI)
Corresponding author
Koulu, Markku
Venue
PLoS ONE
Published
2013-02-15
Volume
8
Issue
2
Pages
e56594
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2063226778
Cited by
92
References
64
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 11 · 2022: 3 · 2021: 16 · 2020: 6 · 2019: 6 · 2018: 19 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 7 · 2013: 2
FWCI
4.36
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Aaltodoc (Aalto University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Kela
  • Academy of Finland (134131)
  • Turun Yliopisto
  • Turun Yliopistollinen Keskussairaala
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
metformin, prenatal drug exposure, developmental programming, high-fat diet, glucose tolerance, GLUT4, INSIG1, hepatic gene expression, adipose tissue, weight gain, polycystic ovary syndrome, gestational diabetes mellitus
MeSH terms
Animals, Body Weight, Eating, Female, Fetus, Gene Expression Regulation, Glucose Tolerance Test, Hypoglycemic Agents, Liver, Male, Membrane Proteins, Metformin, Mice, Inbred C57BL, Organ Size, Phenotype, Pregnancy, Prenatal Exposure Delayed Effects, Maternal Exposure, Glucose Transporter Type 4, Mice, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood. https://app.cochat.ai/papers/10.1371/journal.pone.0056594
The paper
Salomäki, H., Vähätalo, L. H., Laurila, K., Jäppinen, N. T., Penttinen, A.-M., Ailanen, L., Ilyasizadeh, J., Pesonen, U., & Koulu, M. (2013). Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood. PLoS ONE. https://doi.org/10.1371/journal.pone.0056594

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.